Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, Fallopian tube, and primary peritoneal cancer

Van Arsdale, Anne

100 - Featured Poster
Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, Fallopian tube, and primary peritoneal cancer

Monday, March 24, 2014: 7:22 AM

Room 13-16 (Tampa Convention Center)

A. R. Van Arsdale¹, M. H. Einstein¹, M. A. Brewer², P. F. Timmins III³, J. D. Wright⁴, A. L. Leiser⁵, A. B. Astrow⁶, S. Cohen⁷, G. L. Goldberg¹ and D. Y. S. Kuo¹
¹Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, ²University of Connecticut Health Center, Farmington, CT, ³Women's Cancer Care Associates, Albany, NY, ⁴Columbia University College of Physicians and Surgeons, New York, NY, ⁵Beth Israel Medical Center, New York, NY, ⁶Maimonides Medical Center, Brooklyn, NY, ⁷Roosevelt Hospital, New York, NY

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

100 - Featured Poster
Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, Fallopian tube, and primary peritoneal cancer

100 - Featured Poster Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, Fallopian tube, and primary peritoneal cancer

100 - Featured Poster
Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, Fallopian tube, and primary peritoneal cancer